Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mandibuloacral dysplasia
(
MAD
) is a syndrome with onset in midchildhood. The predominant characteristics of
MAD
include flexion contractures; mandibular hypoplasia; loss of body fat; atrophic, speckled skin; and progressive osteolysis of the clavicles. We studied three males with
MAD
. Each had lipodystrophy of the extremities, with sparing of the face and neck. All had moderate hyperlipidemia. In response to oral glucose, each had a diabetic response, with peak insulin levels between 2870 and 22,960 pmol/L. Insulin-stimulated glucose disposal was determined in two patients with
MAD
. At an insulin infusion rate of 120 mU/m2 per minute, glucose disposal was less than 25% of that measured at similar levels of insulinemia in nondiabetic control subjects, indicating marked insulin resistance in patients with
MAD
. The insulin resistance occurred without
obesity
, excessive levels of counterregulatory hormones, or anti-insulin-receptor antibodies. We suggest that
MAD
is a previously undescribed form of lipodystrophic insulin-resistant diabetes mellitus.
...
PMID:Severe insulin resistance and diabetes mellitus in mandibuloacral dysplasia. 173 53